ReviewJournal of experimental & clinical cancer research : CR2021

CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.

Sasan Ghaffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.